ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set

January 25, 1980

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991